Singapore Market Roundup (10-Feb-2026): OCBC raises Boustead Singapore's fair value to $2.45.
OCBC raises Boustead Singapore's fair value to $2.45; DBS and RHB maintain 'buy' on Elite UK REIT; OCBC lowers Sheng Siong to 'hold' but raises...
354 Views
Singapore Market Roundup (30-Jan-2026): CSE Global rated 'buy' by Beansprout, target $1.40.
Beansprout rates CSE Global 'buy' at $1.40. DBS lifts Nam Cheong to $1.60, labeling it a 'hidden gem.' CGSI keeps 'add' on Genting SG for earnings...
269 Views
Singapore Market Roundup (23-Jan-2026): Seatrium endures 'arbitration noise' but CGSI and Citi
Seatrium encounters arbitration issues, but CGSI and Citi remain optimistic. RHB keeps 'buy' on Raffles Medical, while CGSI sees re-rating...
196 Views
Singapore Market Roundup (07-Jan-2026): CGSI lowers Lum Chang Creations' TP to 72 cents, sees
CGSI lowers Lum Chang Creations' target price to 72 cents; JP Morgan raises CDL's to $10.75. OCBC's Carmen Lee sees STI potentially reaching 5,000...
321 Views
Singapore Market Roundup (06-Jan-2026): OCBC's Carmen Lee predicts STI may hit 5,000 points.
STI may hit 5,000 points, says OCBC's Carmen Lee. CGS International reevaluates Raffles Medical Group for 2HFY2025. UOBKH maintains 'buy' on...
538 Views